Wagman R1 | Rouanet P2 | Hyams DM3 | Kuvshinoff B4 | Valentini V5 | Francois Y6 | Grann A7 | Sauer R8 | Gambacorta M9 | Rengan R10 | |
Treatment | RT | RT | CMT | CMT | CMT | RT | CMT | CMT | CMT | RT |
Total number enrolled | 36 | 37 | 59* | 37 | 83 | 201 | 72 | 392¶ | 54 | 27 |
Number who underwent surgery | 35 | 27 | 59 | 36 | 81 | 34 | 72 | NR | 54 | 27 |
Number judged to need an APR | 36 | 37 | 40 | 37 | 47 | 34* | 35 | 105 | 20 | 27 |
Number with T3 disease | 31 (86%) | 12 (32%) | NR (100%) | NR | 83 (66%) | 62 (44%) | 72 (100%) | NR | 52 (96%) | 0 (all cT2) |
Number who underwent LAR and/or coloanal anastomosis | 27 (77%) | 17 (63%) | 30 (75%) | 28 (78%) | 31 (66%) | 15 (44%) | 68 (94%) | 41 (39%) | 13 (65%) | 21 (78%) |
Percent local failure | 17 | 8 | NR | 11 | 10 | 12 | 2 | 7 | 4 | 10 |
Percent survival | 64% 5-year | 83% 2-year | NR | 87%Δ | 72% 5-year | 75% 3-year | 95% 3-year | 78% 5-year | 92% 2-year | 86% 5-year |
Number evaluable for sphincter function analysis | 27 (77%) | 14 (52%) | NR | NR | 63 | 82§ | 21 | NR | NR | 21 |
Sphincter function | 85% good to excellent | 75% perfect | NR | NR | 6% moderate soilage | 78% normal | 81% good to excellent | NR | NR | 77% good to excellent at 2 to 3 years |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟